Business Context and Reporting Period
This Form 8-K is filed by Global Medical REIT Inc. (GMRE), not Chiron Real Estate Inc., with a report date of March 4, 2020. The filing announces financial results for the three- and twelve-month periods ended December 31, 2019, and declares dividends for the first quarter of 2020.
Key Financial Metrics
The filing text references a press release and earnings supplemental containing detailed financial data but does not explicitly state specific values for revenue, profit, cash flow, margins, debt, or liquidity within this document. Investors must refer to the incorporated exhibits (Exhibit 99.1 and 99.2) for these figures.
Material Changes and Dividend Declarations
On March 3, 2020, the Company declared the following cash dividends:
- Common Stock: $0.20 per share for the first quarter of 2020. Record date: March 25, 2020; Payment date: April 9, 2020.
- Series A Preferred Stock: $0.46875 per share for the period January 31, 2020, through April 29, 2020. Record date: April 15, 2020; Payment date: April 30, 2020.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release and Fourth Quarter 2019 Earnings Supplemental which contain management commentary and operational results. The text explicitly states that the information in Item 2.02 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. No specific guidance, risks, or contingencies are detailed in the body of this 8-K.
Investor Verification Checklist
- Verify the correct registrant name is Global Medical REIT Inc. (GMRE), as the input metadata incorrectly listed Chiron Real Estate Inc.
- Review Exhibit 99.1 (Press Release) and Exhibit 99.2 (Earnings Supplemental) for specific revenue, FFO, and balance sheet metrics, as they are not listed in the 8-K text.
- Confirm dividend record dates and payment schedules for both common and Series A preferred shareholders.
- Note that the financial data referenced is not legally "filed" for liability purposes under Section 18 of the Exchange Act.